← Leaderboards
Scott A. Rivkees
Yale University
$12,932,817
Attributed
$13,283,113
Total exposure
16
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$12,483,113 · 15
FDA$800,000 · 1
By mechanism
R01$9,437,970 · 7
R42$1,917,766 · 1
R21$1,212,593 · 3
R41$707,793 · 4
P41$6,991 · 1
Top collaborators
- Richard Wagner1 shared
Most similar at Yale University
Same institution · by research overlap
- Linda May Bartoshuk$4,121,541
- Laura R. Ment$24,806,596
- Trevor J Williams$14,233,211
- Stephen M Strittmatter$76,187,371
- Diego Javier Rodriguez-Gil$911,421
Others in their field
Top investigators on “Infant”
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Carol Nesel · Westat$188,148,170
- Barbara Driver · Westat, Inc.$184,782,231
- Abhik Das · Research Triangle Institute$178,442,979
- Elizabeth A Thom · George Washington University$170,837,172
- J Brooks Jackson · Social And Scientific Systems, Inc.$150,941,831
Research focus
InfantLaboratory MouseAffectChildUnited StatesPreventPlayTissue /Cell CultureOligodendrogliaEtiologyNovel StrategiesNovel TherapeuticsDoseCerebral PalsyPurinergic ReceptorPeriventricular White Matter InjuryAdenosineMyelinationBrainBrain InjuriesLeadDiffuseClinical ResearchWhite Matter
Grant awards (40)
Prevention of White Matter Injury in Premature Infants$700,593
R42 · FY2021 · HD
Prevention of White Matter Injury in Premature Infants$993,274
R42 · FY2020 · HD · contact PI
Development of a Novel Therapeutic for Hyperthyroidism$225,000
R41 · FY2019 · DK · contact PI
Prevention of White Matter Injury in Premature Infants$223,899
R42 · FY2019 · HD · contact PI
Radioactive Iodide Therapy of Pediatric Graves' Disease$400,000
R01 · FY2015 · FD · contact PI
Discovery of Oligodendrocyte Stimulators$217,801
R41 · FY2015 · NS · contact PI
Graves' Disease Therapy Risks to Mother and Fetus$462,925
R01 · FY2013 · HD · contact PI
Periventricular White Matter Injury Prevention$388,759
R01 · FY2013 · NS · contact PI
Periventricular White Matter Injury Prevention$402,296
R01 · FY2012 · NS · contact PI
Graves' Disease Therapy Risks to Mother and Fetus$399,281
R01 · FY2012 · HD · contact PI
Periventricular White Matter Injury Prevention$46,776
R01 · FY2012 · NS · contact PI
Graves' Disease Therapy Risks to Mother and Fetus$679,971
R01 · FY2011 · HD · contact PI
Periventricular White Matter Injury Prevention$354,791
R01 · FY2011 · NS · contact PI
Graves' Disease Therapy Risks to Mother and Fetus$728,127
R01 · FY2010 · HD · contact PI
Adenosinergic Mechanisms of Intrauterine Growth Retardation$410,198
R01 · FY2010 · HD · contact PI
Periventricular White Matter Injury Prevention$362,031
R01 · FY2010 · NS · contact PI
Radioactive Iodide Therapy of Pediatric Graves' Disease$311,605
R01 · FY2010 · FD · contact PI
Radioactive Iodide Therapy of Pediatric Graves' Disease$88,395
R01 · FY2010 · FD · contact PI
Adenosinergic Mechanisms of Intrauterine Growth Retardation$413,750
R01 · FY2009 · HD · contact PI
Anti-Adenosine Therapy of Neonatal Brain Injury$170,280
R21 · FY2007 · NS · contact PI
Anti-Adenosine Therapy of Neonatal Brain Injury$183,938
R21 · FY2006 · NS · contact PI
Newborn Screening for Sex Chromosome Disorders$129,953
R41 · FY2006 · HD · contact PI
A-1 Adenosine Receptor Action in Developing Heart$327,000
R01 · FY2005 · HL
CB1 Receptor Action on the Developing Hippocampus$204,375
R21 · FY2005 · DA
A-1 Adenosine Receptor Action in Developing Heart$327,000
R01 · FY2004 · HL
CB1 Receptor Action on the Developing Hippocampus$245,250
R21 · FY2004 · DA
DIFFUSION WEIGHTED IMAGING BY 3D GPSW SPIN ECHO SEQUENCE TO ACQUIRE 12 IMAGES EN$6,991
P41 · FY2004 · RR
A1-ADENOSINE RECEPTOR ACTION IN HIPPOCAMPUS$327,000
R01 · FY2003 · NS
A-1 Adenosine Receptor Action in Developing Heart$327,000
R01 · FY2003 · HL
The Role of Adenosine in Hypoglycemic Brain Injury$204,375
R21 · FY2003 · NS
Vaccine therapy of congenital adrenal Hyperplasia$135,039
R41 · FY2003 · DK
DEVELOPING CIRCADIAN RHYTHMICITY$372,322
R01 · FY2002 · NS
A1-ADENOSINE RECEPTOR ACTION IN HIPPOCAMPUS$327,000
R01 · FY2002 · NS
A-1 Adenosine Receptor Action in Developing Heart$327,000
R01 · FY2002 · HL
The Role of Adenosine in Hypoglycemic Brain Injury$204,375
R21 · FY2002 · NS
DEVELOPING CIRCADIAN RHYTHMICITY$375,375
R01 · FY2001 · NS
A1-ADENOSINE RECEPTOR ACTION IN HIPPOCAMPUS$327,000
R01 · FY2001 · NS
DEVELOPING CIRCADIAN RHYTHMICITY$354,816
R01 · FY2000 · NS
A1-ADENOSINE RECEPTOR ACTION IN HIPPOCAMPUS$327,000
R01 · FY2000 · NS
ADENOSINE ACTION IN THE DEVELOPING HEART$270,552
R01 · FY2000 · HL